Tech Company Financing Transactions
Azitra Funding Round
Azitra secured a $2.9 million Series A funding round on 4/6/2017. Investors included Bios Partners and private investors.
Transaction Overview
Company Name
Announced On
4/6/2017
Transaction Type
Venture Equity
Amount
$2,900,000
Round
Series A
Investors
Bios Partners (Lead Investor) (Aaron Fletcher)
private investors (Peter Thiel)
Proceeds Purpose
The funding will allow Azitra to continue testing its platform across a variety of skin conditions such as eczema, rare genetic skin diseases and cosmetic applications.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
400 Farmington Ave.
Farmington, CT 06032
USA
Farmington, CT 06032
USA
Phone
Website
Email Address
Overview
Azitra, Inc. biopharmaceutical company that aims to harness the power of the microbiome on the skin. Since 2014, the company has been working with world-leading scientists in dermatology, microbiology, and microbiomics to improve and test its platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Andrews
Chief Scientific Officer
Mark Sampson
Co-Founder
Travis Whitfill
VP - Bus. Development
Roger Leger
VP - Product Management
Gilles Dube
VP - R & D
Trudy Grossman
Browse more venture capital transactions:
Prev: 4/6/2017: Bus.com venture capital transaction
Next: 4/6/2017: Intelivideo venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are derived from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs